The promise of biological markers for treatment response in first-episode psychosis: a systematic review.
about
Birth by cesarean section and schizophrenia: results from the multicenter FACE-SZ data-set.Theranostic Biomarkers for SchizophreniaA double amino-acid change in the HLA-A peptide-binding groove is associated with response to psychotropic treatment in patients with schizophreniaChronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset.Concomitant NSAID use during antipsychotic treatment and risk of 2-year relapse - a population-based study of 16,253 incident patients with schizophrenia.Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations.Personalized medicine for schizophrenia.Going beyond "trial-and-error" in psychiatric treatments: OPTiMiSE-ing the treatment of first episode of schizophrenia.Inflammation, Stress Response, and Redox Dysregulation Biomarkers: Clinical Outcomes and Pharmacological Implications for Psychosis.Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort.Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort.Cardiovascular Risk in Early Psychosis: Relationship with Inflammation and Clinical Features 6 Months after Diagnosis.Autoimmune phenotypes in schizophrenia reveal novel treatment targets.Blood-Based Lipidomics Approach to Evaluate Biomarkers Associated With Response to Olanzapine, Risperidone, and Quetiapine Treatment in Schizophrenia Patients.C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic ReviewElevated allostatic load early in the course of schizophrenia
P2860
Q31111007-81181720-7A0D-4E4A-9BCC-E619EBB52589Q33624412-8361E6D6-55FA-44D5-871C-8FED97CB7EAEQ37347570-AED1CFD1-D190-478C-8323-FCE441817D67Q38392954-FDDFCD33-DE3F-48A7-BD5D-21B1EA9EF61EQ40847189-5118A832-BE8D-4314-BF38-EF767681DBB4Q41611297-BF32A2DC-F2C7-4BEB-B9B3-F239760A83FDQ42347524-AD24076B-25E9-443E-866D-7188B598F1D2Q43088144-75826F5F-AA72-4767-AB31-742A652B8048Q46070080-34927DD7-0876-460F-9463-0F5BF1DA1645Q47582903-35555239-76BF-44C3-9A8D-D9C1223B8A39Q47760005-E8037710-8C14-446D-B4C2-3CFFFB987F44Q52755746-F3DFF08C-03A7-4F3E-B79C-AE3ED0003527Q54217096-6D12220F-F6A6-4B45-9BC6-8EDE71D6B719Q54942497-DC049A5D-06F7-4E05-9FAA-8EDE0DC652F3Q58712660-5A27B196-4958-44BC-A3BE-1217837232B1Q59129742-8F6B2B1D-EF3C-48B7-A7E2-E5664686D94D
P2860
The promise of biological markers for treatment response in first-episode psychosis: a systematic review.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The promise of biological mark ...... sychosis: a systematic review.
@ast
The promise of biological mark ...... sychosis: a systematic review.
@en
type
label
The promise of biological mark ...... sychosis: a systematic review.
@ast
The promise of biological mark ...... sychosis: a systematic review.
@en
prefLabel
The promise of biological mark ...... sychosis: a systematic review.
@ast
The promise of biological mark ...... sychosis: a systematic review.
@en
P2093
P2860
P50
P356
P1476
The promise of biological mark ...... sychosis: a systematic review.
@en
P2093
Inge Winter-van Rossum
Marc-Antoine d'Albis
Markus Leweke
Phillip McGuire
Ryad Tamouza
Shitij Kapur
Shôn Lewis
W Wolfgang Fleischhacker
P2860
P304
P356
10.1093/SCHBUL/SBV002
P407
P50
P577
2015-03-10T00:00:00Z